Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1876]
News [4309]
Articles [404]
Editorials [10]
Conferences [107]
elearning [41]
Screening for breast cancer, how often?
Dr James Mackay - University College London, UK
Screening for breast cancer, how often? ( Dr James Mackay - University College London, UK )
12 Feb 2010
IMPAKT 2009 and the future
Dr Christos Sotiriou - Jules Bordet Institute, Belgium
IMPAKT 2009 and the future ( Dr Christos Sotiriou - Jules Bordet Institute, Belgium )
12 Feb 2010
Translational breast cancer research
Dr Fabrice Andre - Institut Gustave Roussy, France
Translational breast cancer research ( Dr Fabrice Andre - Institut Gustave Roussy, France )
12 Feb 2010
The aims of Susan G. Komen for the Cure
Nancy Brinker - Susan G. Komen for the Cure
The aims of Susan G. Komen for the Cure ( Nancy Brinker - Susan G. Komen for the Cure )
12 Feb 2010
Exchanging scientific information
Dr Phillipe Bedard - Breast International Group
Exchanging scientific information ( Dr Phillipe Bedard - Breast International Group )
12 Feb 2010
Bisphosphonates for breast cancer patients
Prof Michael Gnant - Medical University of Vienna, Austria
Bisphosphonates for breast cancer patients ( Prof Michael Gnant - Medical University of Vienna, Austria )
9 Feb 2010
Typical course for receptor positive early breast cancer
Dr Kimberly Blackwell - Duke University Medical Centre, USA
Typical course for receptor positive early breast cancer ( Dr Kimberly Blackwell - Duke University Medical Centre, USA )
9 Feb 2010
Oral bisphosphonate and breast cancer: prospective results from the Women's...
Dr Rowan Chlebowski - Harbor-University of California, Los Angeles
Oral bisphosphonate and breast cancer: prospective results from the Women's Health Initiative (WHI) ( Dr Rowan Chlebowski - Harbor-University of California, Los Angeles )
28 Jan 2010
Use of bisphosphonates and risk of postmenopausal breast cancer
Dr Gad Rennert - Technion-Israel Institute of Technology, Israel
Use of bisphosphonates and risk of postmenopausal breast cancer ( Dr Gad Rennert - Technion-Israel Institute of Technology, Israel )
28 Jan 2010
Denosumab versus zoledronic acid for skeletal-related events in breast cancer...
Dr Alison Stopeck - University of Arizona Cancer Center
Denosumab versus zoledronic acid for skeletal-related events in breast cancer patients with bone metastases ( Dr Alison Stopeck - University of Arizona Cancer Center )
28 Jan 2010
Short term biological effects of the combination of letrozole and zoledronic...
Prof Nigel Bundred - University of Manchester, UK
Short term biological effects of the combination of letrozole and zoledronic acid on invasive breast cancer ( Prof Nigel Bundred - University of Manchester, UK )
28 Jan 2010
Targeting intrinsically-resistant breast cancer stem cells with gamma-secretase...
Prof Jenny Chang - Baylor College of Medicine, USA
Targeting intrinsically-resistant breast cancer stem cells with gamma-secretase inhibitors ( Prof Jenny Chang - Baylor College of Medicine, USA )
28 Jan 2010

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation